Your session is about to expire
← Back to Search
Thyroid Lobectomy for Thyroid Cancer (MAPS Trial)
MAPS Trial Summary
This trial is studying the use of molecular analysis in thyroid cancer to determine the best type of surgery. The researchers believe that using molecular analysis can provide important information about the cancer and help guide the decision between
MAPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMAPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MAPS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are researchers currently seeking participants for this study?
"Indeed, the data available on clinicaltrials.gov indicates that this trial is presently seeking eligible participants. The study was initially posted on February 21st, 2024 and was last updated on January 29th, 2024. The research team aims to recruit a total of 125 patients from a single designated site."
What is the total number of participants enrolled in this research investigation?
"Indeed, the information found on clinicaltrials.gov confirms that this study is currently seeking eligible individuals. The trial was initially listed on February 21st, 2024 and most recently updated on January 29th, 2024. A total of 125 participants will be enrolled at a single site."
Share this study with friends
Copy Link
Messenger